←Back to Expert Scholars
Translational Medicine / 转化医学Pan RAS Inhibitors
Ryan Corcoran
MD, PhD
🏢Massachusetts General Hospital🌐USA
Director, Gastrointestinal Cancer Center
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ryan Corcoran leads clinical and translational research on KRAS mutant colorectal cancer and pan RAS therapeutic strategies. His work has defined rational combinations with EGFR and SHP2 inhibitors and characterized resistance mechanisms. He is a leader in GI precision oncology.
Share:
🧪Research Fields 研究领域
colorectal cancer
KRAS
combination therapy
resistance
ctDNA
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ryan Corcoran 的研究动态
Follow Ryan Corcoran's research updates
留下邮箱，当我们发布与 Ryan Corcoran（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment